nimodipine has been researched along with Active Hyperemia in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hawkes, MA | 1 |
Hlavnicka, AA | 1 |
Wainsztein, NA | 1 |
Rhee, RY | 1 |
Gloviczki, P | 1 |
Cambria, RA | 1 |
Lowell, RC | 1 |
Okazaki, H | 1 |
2 other studies available for nimodipine and Active Hyperemia
Article | Year |
---|---|
Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone.
Topics: Adult; Angiography, Digital Subtraction; Aphasia, Broca; Brain Edema; Cerebral Hemorrhage; Computed | 2020 |
The effects of nimodipine on ischemic injury of the spinal cord during thoracic aortic cross-clamping.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Constriction; Dogs; Hyperemia; Laser-Doppler Flo | 1996 |